Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Got $100? 1 Artificial Intelligence (AI) Memory ETF to Buy Right Now.: https://g.foolcdn.com/editorial/images/879501/professional_smiling_in_the_office.jpg
Got $100? 1 Artificial Intelligence (AI) Memory ETF to Buy Right Now.

Artificial intelligence chips need to process massive amounts of data quickly -- and to access it in an optimal way, they need that data stored nearby on high bandwidth memory (HBM) chips.

For

Why Wall Street Can't Get Enough of This Dividend King: https://g.foolcdn.com/editorial/images/878955/25_06_22-blocks-spelling-yield-with-coins-on-top-of-them-and-a-pen-in-front-_mf-dload-gettyimages-1313556813-1201x798-36b7a2e.jpg
Why Wall Street Can't Get Enough of This Dividend King

AbbVie (NYSE: ABBV) was spun off from Abbott (NYSE: ABT) in 2013. That's an important fact to keep in mind when you look at AbbVie's Dividend King status. Technically, it hasn't increased its

Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.: https://g.foolcdn.com/editorial/images/878956/23_02_20-a-list-set-up-for-showing-the-pros-and-cons-or-disadvantages-and-advantages-of-an-investment-_mf-dload.jpg
Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.

Pfizer (NYSE: PFE) has a shockingly high dividend yield of 6.8%. The S&P 500 Index (SNPINDEX: ^GSPC) has a 1% yield, and the average pharmaceutical stock's yield is roughly 1.5%. Given that huge

This Capricor Insider Sold 24,000 Shares Before the Drop. With a New Catalyst on the Way, Is It Time to Buy?Photo, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
This Capricor Insider Sold 24,000 Shares Before the Drop. With a New Catalyst on the Way, Is It Time to Buy?

Karen Krasney, EVP, General Counsel of Capricor Therapeutics (NASDAQ:CAPR), reported the exercise of 24,100 stock options and immediate sale of the underlying common shares for a total transaction

Is SoFi Technologies Stock a Bargain After Its Big Drop, or a Falling Knife?: https://g.foolcdn.com/editorial/images/879613/sofi-technologies-logo.png
Is SoFi Technologies Stock a Bargain After Its Big Drop, or a Falling Knife?

After a couple of years of beating the market, SoFi Technologies (NASDAQ: SOFI) has lost its momentum. The fintech specialist's shares have declined 39% since January. What's more, there are still

These 3 Healthcare Stocks Have Crushed the Market This Year. Here's Why There's More Upside Ahead: https://g.foolcdn.com/editorial/images/879595/doctor-and-patient-talking.jpg
These 3 Healthcare Stocks Have Crushed the Market This Year. Here's Why There's More Upside Ahead

If you had invested in Krystal Biotech (NASDAQ: KRYS), Exelixis (NASDAQ: EXEL), or CVS Health (NYSE: CVS) at the beginning of the year, you'd be sitting pretty. All three companies have outpaced the

Advanced Micro Devices vs. Alphabet: What Do the Revenue Trajectories of These Artificial Intelligence Companies Tell Investors?: https://g.foolcdn.com/charts/production/processed/amd-googl/quarter/revenue/bar/primary/standard/limit-8/latest/amd-googl_quarter_revenue_bar_primary_standard_limit8.png
Advanced Micro Devices vs. Alphabet: What Do the Revenue Trajectories of These Artificial Intelligence Companies Tell Investors?

Advanced Micro Devices (NASDAQ:AMD) primarily generates its revenue by selling microprocessors and graphics processing units to original equipment manufacturers, public cloud service providers, and

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plcPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
EQS-Adhoc: BB Biotech AG publishes its interim report and revises its dividend policyPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
EQS-Adhoc: BB Biotech AG publishes its interim report and revises its dividend policy
EQS-Adhoc: BB Biotech AG publishes its interim report and revises its dividend policy
EQS-News: BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioningPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
EQS-News: BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning
EQS-News: BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning
2 Missions, 3 Launches, and Up to $300 Million for Rocket Lab: https://g.foolcdn.com/editorial/images/880068/11252024-close-up-view-if-engine-firing-at-electron-rocket-launch-from-lc-1-in-new-zealand-is-rocket-lab.jpg
2 Missions, 3 Launches, and Up to $300 Million for Rocket Lab

Rocket Lab (NASDAQ: RKLB) is on a roll -- not that you could tell from the stock price.

Shares of the tiny, U.S.- and New Zealand-based Space Exploration Technologies lookalike are down 32% so far

BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring: https://g.foolcdn.com/editorial/images/879604/doctor-and-patient-in-a-hospital-room.jpg
BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring

BioNTech (NASDAQ: BNTX) rose to prominence several years ago thanks to its role in the coronavirus market. The company developed Comirnaty, one of the best-selling COVID-19 vaccines, with Pfizer

Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer: https://g.foolcdn.com/editorial/images/879600/pfizer-logo.png
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer

We can separate high-yield dividend stocks into two broad categories. The first group consists of companies with stable businesses that generate consistent cash flow and are very likely to continue

EQS-News: Abivax Strengthens Commercial Capabilities With Strategic Leadership AppointmentsPhoto, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
EQS-News: Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
EQS-News: Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Astera Labs vs. Advanced Micro Devices: What the Revenue Trajectories of These Artificial Intelligence Companies Reveal to Investors.: https://g.foolcdn.com/charts/production/processed/alab-amd/quarter/revenue/bar/primary/standard/limit-8/latest/alab-amd_quarter_revenue_bar_primary_standard_limit8.png
Astera Labs vs. Advanced Micro Devices: What the Revenue Trajectories of These Artificial Intelligence Companies Reveal to Investors.

Astera Labs (NASDAQ:ALAB) develops and markets semiconductor-based connectivity solutions for cloud computing and artificial intelligence infrastructure.

It expanded its operations in Taiwan in June

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plcPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
EQS-News: Fresenius establishes venture fund of more than €200 million to drive healthcare innovationPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
EQS-News: Fresenius establishes venture fund of more than €200 million to drive healthcare innovation
EQS-News: Fresenius establishes venture fund of more than €200 million to drive healthcare innovation
EQS-News: Gerresheimer Starts Operations at New Plant in Zhenjiang Dagang, ChinaPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
EQS-News: Gerresheimer Starts Operations at New Plant in Zhenjiang Dagang, China
EQS-News: Gerresheimer Starts Operations at New Plant in Zhenjiang Dagang, China
EQS-News: Sartorius maintains positive momentum and continues to grow profitably: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: Sartorius maintains positive momentum and continues to grow profitably
EQS-News: Sartorius maintains positive momentum and continues to grow profitably
A BeOne Founder Sold $34.6 Million in Stock but Keeps a Massive PositionPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
A BeOne Founder Sold $34.6 Million in Stock but Keeps a Massive Position

John Oyler, the chief executive officer of BeOne Medicines AG (NASDAQ:ONC), sold 109,713 American Depositary Shares in transactions executed on July 20, 2026, and July 21, 2026, according to an SEC

Why AT&T Stock Rallied Today: https://g.foolcdn.com/editorial/images/880273/t-stock.png
Why AT&T Stock Rallied Today

Shares of AT&T (NYSE: T) rose on Wednesday after the wireless carrier delivered reassuring financial results and reaffirmed its long-term growth forecast.

Image source: The Motley Fool.

AT&T saw

Stock Market Today, July 22: AT&T Beats Earnings on Strong Wireless Subscriber GrowthPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Stock Market Today, July 22: AT&T Beats Earnings on Strong Wireless Subscriber Growth

AT&T (NYSE:T), a nationwide wireless and broadband carrier, closed at $23.04, up 3.50%. Earnings and subscriber growth data beat estimates, even as revenue missed expectations.Trading volume reached

VALBIOTIS SA: Results of the REVERSE-IT clinical study published in Nature Communications, a major international scientific recognition for the ingredient Totum•63Photo, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
VALBIOTIS SA: Results of the REVERSE-IT clinical study published in Nature Communications, a major international scientific recognition for the ingredient Totum•63
VALBIOTIS SA: Results of the REVERSE-IT clinical study published in Nature Communications, a major international scientific recognition for the ingredient Totum•63
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow: https://g.foolcdn.com/editorial/images/879594/abbvie-logo.png
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow

AbbVie (NYSE: ABBV) has performed fairly well this year despite significant volatility. The company's shares are up 10%, slightly above the S&P 500's 8% return. Will the healthcare leader maintain

Stock Market Today, July 21: Micron Surges 12% as Semiconductor Strength Lifts NasdaqPhoto, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
Stock Market Today, July 21: Micron Surges 12% as Semiconductor Strength Lifts Nasdaq

The Nasdaq Composite (NASDAQINDEX:^IXIC) gained 1.29% to 25,837, the S&P 500 (SNPINDEX:^GSPC) rose 0.89% to 7,509 ,and the Dow Jones Industrial Average (DJINDICES:^DJI) added 0.74% to 52,225